The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth

Journal of Clinical Periodontology

Volumn 26, Issue 12, 1999, Pages 802-805

  Kamali, F ^a   McLaughlin, W S ^a   Ball, D E ^a   Seymour, R A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

4 HPPH; Drug metabolism; Epilepsy; Gingival overgrowth; Phenytoin

Indexed keywords

5 (4 HYDROXYPHENYL) 5 PHENYLHYDANTOIN; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; PHENYTOIN;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; EPILEPSY; FEMALE; GINGIVA OVERGROWTH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MIDDLE AGED; SALIVA; TIME;

ADULT; ANTICONVULSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GINGIVAL OVERGROWTH; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; SALIVA; TIME FACTORS;

EID: 0033252483     PISSN: 03036979     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-051X.1999.tb02523.x     Document Type: Article

References (24)

1. Addy, V., McElay, J. C., Eyre, G., Campbell, N. & D'Arcy, P. F: (1983) Risk factors in phenytoin-induced gingival hyperplasia. Journal of Periodontology 54, 373-377.
2. Angelopoulos, A. P. (1975) Diphenylhydantoin gingival hyperplasia. A clinicopathological review. 1. Incidence, clinical features and histopathology. Journal of Canadian Dental Association 41, 103-106.
3. Ball, D., McLaughlin, W. S., Seymour, R. A. & Kamali, F. (1996) Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients. Journal of Periodontology 67, 597-602.
4. Chang, T. & Glazko, A. J. (1982) Phenytoin biotransformation. In: Woodbury, D. M., Penry, J. K. & Pippenger, C. E. (eds). Anti-epileptic drugs, 2nd edition. New York: Raven Press, pp. 209-226.
5. Dahllof, G. & Modeer, T. (1986) The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study. Journal of Clinical Periodontology 13, 845-849.
6. Hassell, T. M. & Page, R. C. (1978) The major metabolite of phenytoin (Dilantin) induces gingival overgrowth in cats. Journal of Periodontol Research 13, 280-282.
7. Hassell, T. M. (1981) Epilepsy and the oral manifestations of phenytoin therapy. In: Myers, H. M. (ed.): Monographs in oral science, vol. 9 Basel, Karger: pp. 116-202.
8. Hassell, T. M., O'Donnell, J., Pearlman, J., Tesini, D., Murphy, T. & Best, H. (1984) Phenytoin-induced gingival overgrowth in institutionalised epileptics. Journal of Clinical Periodontology 11, 242-253.
9. Hassell, T. M. & Hefti, A. F. (1991) Drug-induced gingival overgrowth: old problem, new problem. Critical Reviews in Oral Pathology and Medicine 2, 103-137.
10. Kabra, P. M., Nelson, M. A. & Marton, L. J. (1983) Simultaneous very fast liquid-chromatographic analysis of ethosuximide, primidone, phenobarbital, phenytoin and carbamazepine in serum. Clinical Chemistry 29, 473-476.
11. Kamali, F. & Thomas, S. H. L. (1994) Effect of saliva flow rate on saliva phenytoin concentrations: implications for therapeutic monitoring. European Journal of Clinical Pharmacology 46, 565-567.
12. Kapur, R. N., Girias, S., Little, T. M. & Mosotti R. E. (1973) Diphenylhydantoin-induced gingival hyperplasia: its relation to dose and serum level. Developmental Medicine and Child Neurology 15, 483-487.
13. Kimball, O. P. (1939) The treatment of epilepsy with sodium diphenyl hydantoinate. Journal of the American Medical Association 112, 1244-1245.
14. King, D. A., Hawes, R. R. & Bibby, B. G. (1976) The effect of oral physiotherapy on dilantin gingival hyperplasia. Journal of Oral Pathology 5, 1-7.
15. Kutt, H. (1975) Interactions of antiepileptic drugs. Epilepsia 16, 393-402.
16. Little, T. M., Girgis, S. S. & Masotti, R. E. (1975) Diphenylhydantoin-induced gingival hyperplasia: Its response to changes in drug dosage. Developmental Medicine and Child Neurology 17, 421-424.
17. Maguire, J. H., Greenwood, R. S., Lewis, D. V. & Hassell, T. M. (1986) Phenytoin-induced gingival overgrowth is dependent upon co-medication (abstract). Journal of Dental Research 65, 249.
18. Modeer, T. & Dahllof, G. (1987) Development of phenytoin-induced gingival overgrowth in non-institutionalised epileptic children subjected to different plaque control programs. Acta Odontol. Scand 45, 81-85.
19. Paxton, J. W., Whiting, B. & Stephen, K. W. (1977) Phenytoin concentrations in mixed, parotid, submandibular saliva and serum measured by radioimmunoassay. British Journal of Clinical Pharmacology 4, 185-191.
20. Penarrocha-Diego, M., Bagan-Sebastian, J. V. & Vera-Sempere, F. (1990) Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study. Journal of Periodontology 61, 571-574.
21. Seymour, R. A., Smith, D. G. & Turnbull, D. N. (1985) The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. Journal of Clinical Periodontology 12, 413-419.
22. Seymour, R. A., Thomason, T. M. & Ellis, J. S. (1996) The pathogenesis of drug-induced gingival overgrowth. Journal of Clinical Periodontology 23, 165-175.
23. Sooriymoorthy, M., Harvey, W. & Gower, D. B. (1988) The use of gingival fibroblasts in culture for studying the effects of phenytoin on testosterone metabolism. Archives of Oral Biology 33, 353-359.
24. Thomason, J. M., Seymour, R. A. & Rawlins, M. D. (1992) Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice. Community Dental Oral Epidemiology 20, 288-291.